Callahan Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,704
Closed -$2.74M 184
2025
Q3
$2.74M Buy
18,704
+296
+2% +$44.7K 0.23% 76
2025
Q2
$2.87M Buy
18,408
+4,020
+28% +$637K 0.26% 75
2025
Q1
$2.37M Buy
14,388
+1,283
+10% +$213K 0.23% 85
2024
Q4
$2.14M Buy
13,105
+6,221
+90% +$1.11M 0.2% 86
2024
Q3
$1.34M Buy
6,884
+306
+5% +$56.4K 0.13% 96
2024
Q2
$1.14M Buy
6,578
+401
+6% +$66.7K 0.12% 96
2024
Q1
$1.05M Sell
6,177
-134
-2% -$25.1K 0.11% 96
2023
Q4
$1.25M Buy
6,311
+23
+0.4% +$4.07K 0.14% 86
2023
Q3
$1.09M Sell
6,288
-168
-3% -$30.5K 0.14% 89
2023
Q2
$1.11M Sell
6,456
-1,071
-14% -$185K 0.14% 90
2023
Q1
$1.25M Sell
7,527
-3,882
-34% -$636K 0.16% 94
2022
Q4
$1.67M Sell
11,409
-1,827
-14% -$270K 0.23% 71
2022
Q3
$1.96M Sell
13,236
-679
-5% -$113K 0.28% 71
2022
Q2
$2.39M Sell
13,915
-1,802
-11% -$312K 0.32% 70
2022
Q1
$2.96M Sell
15,717
-1,282
-8% -$253K 0.34% 73
2021
Q4
$4.15M Sell
16,999
-150
-0.9% -$32.9K 0.47% 59
2021
Q3
$3.33M Sell
17,149
-629
-4% -$127K 0.42% 63
2021
Q2
$3.31M Sell
17,778
-479
-3% -$83.2K 0.42% 62
2021
Q1
$2.88M Buy
18,257
+76
+0.4% +$12K 0.39% 63
2020
Q4
$3.01M Sell
18,181
-257
-1% -$41.8K 0.44% 60
2020
Q3
$3.05M Buy
18,438
+725
+4% +$111K 0.5% 51
2020
Q2
$2.43M Buy
17,713
+3,721
+27% +$486K 0.43% 54
2020
Q1
$1.65M Buy
13,992
+821
+6% +$108K 0.35% 63
2019
Q4
$1.74M Buy
13,171
+1,561
+13% +$194K 0.28% 71
2019
Q3
$1.45M Buy
11,610
+5,160
+80% +$623K 0.25% 73
2019
Q2
$732K Buy
+6,450
New +$675K 0.13% 95

Other funds holding ZTS

Callahan Advisors's ZTS Position: Q4 2025 in Review

Callahan Advisors sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 18,704 shares — an estimated $2.74M sold.

Callahan Advisors first reported a position in ZTS in Q2 2019 and held it in 26 quarters. The position peaked at $4.15M in Q4 2021. 1,679 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • Callahan Advisors reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
  • Callahan Advisors sold 18,704 Zoetis shares in Q4 2025, an estimated $2.74M.
  • Callahan Advisors first reported a position in Zoetis in Q2 2019 and held it in 26 quarters.
  • Callahan Advisors's Zoetis position peaked at $4.15M in Q4 2021.
  • 1,679 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Callahan Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.